TWO SIGMA INVESTMENTS, LP

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1179392 NEW YORK, NY

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,319,809

+$943,362 QoQ

Shares Held

948,517

+54.1% QoQ

Ownership

1.54%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 135 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. VYGR ranks #135 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,319,809	948,517	+54.1%	Shares	Sole	2026-08-14
2026-03-31	$2,376,447	615,660	+176.4%	Shares	Sole	2026-05-15
2025-12-31	$875,262	222,713	+58.3%	Shares	Sole	2026-02-17
2025-09-30	$657,139	140,715	+536.4%	Shares	Sole	2025-11-14
2024-03-31	$205,862	22,112	+0.1%	Shares	Sole	2024-05-15
2023-12-31	$186,524	22,100	-34.2%	Shares	Sole	2024-02-14
2023-09-30	$260,400	33,600	-41.5%	Shares	Sole	2023-11-14
2023-06-30	$657,172	57,395	+120.8%	Shares	Sole	2023-08-14
2023-03-31	$200,460	26,000	-22.2%	Shares	Sole	2023-05-15
2022-06-30	$197,553	33,427	-65.3%	Shares	Sole	2022-08-15
2022-03-31	$735,002	96,457	+616.7%	Shares	Sole	2022-05-16
2021-06-30	$55,585	13,459	-95.9%	Shares	Sole	2021-08-16
2021-03-31	$1,540,141	326,994	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.